EP1765452A4 - Delivery system - Google Patents

Delivery system

Info

Publication number
EP1765452A4
EP1765452A4 EP05769226A EP05769226A EP1765452A4 EP 1765452 A4 EP1765452 A4 EP 1765452A4 EP 05769226 A EP05769226 A EP 05769226A EP 05769226 A EP05769226 A EP 05769226A EP 1765452 A4 EP1765452 A4 EP 1765452A4
Authority
EP
European Patent Office
Prior art keywords
delivery system
vaginal cavity
internal phase
high internal
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05769226A
Other languages
German (de)
French (fr)
Other versions
EP1765452A1 (en
Inventor
Robert C Cuca
Thomas C Riley
R Saul Levinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amag Pharma USA Inc
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of EP1765452A1 publication Critical patent/EP1765452A1/en
Publication of EP1765452A4 publication Critical patent/EP1765452A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B2017/4216—Operations on uterus, e.g. endometrium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A pharmaceutical delivery system that releases an active agent in a controlled manner for an extended period in the vaginal cavity to treat or cure ailments associated with the vaginal cavity or proximal areas. The delivery system includes an applicator which is composed of a high internal phase emulsion, allowing the delivery system to adhere to the mucosal surfaces of the body, primarily the lining of vaginal cavity. The delivery system can maintain the high internal phase emulsion at a temperature of 86°F for at least one month, without decomposition or instability of the emulsion.
EP05769226A 2004-07-08 2005-07-08 Delivery system Withdrawn EP1765452A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58627304P 2004-07-08 2004-07-08
PCT/US2004/022058 WO2006016869A1 (en) 2004-07-08 2004-07-08 Delivery system
PCT/US2005/024200 WO2006014572A1 (en) 2004-07-08 2005-07-08 Delivery system

Publications (2)

Publication Number Publication Date
EP1765452A1 EP1765452A1 (en) 2007-03-28
EP1765452A4 true EP1765452A4 (en) 2012-11-28

Family

ID=35787422

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05769226A Withdrawn EP1765452A4 (en) 2004-07-08 2005-07-08 Delivery system

Country Status (13)

Country Link
EP (1) EP1765452A4 (en)
CN (2) CN102188375A (en)
AU (2) AU2004100776A4 (en)
BR (1) BRPI0513066A (en)
CA (1) CA2572919A1 (en)
CZ (1) CZ15068U1 (en)
ES (1) ES1060042Y (en)
FR (1) FR2872702B3 (en)
MX (2) MXPA04007681A (en)
NL (1) NL1026978C1 (en)
NZ (1) NZ552406A (en)
RU (1) RU2379027C2 (en)
WO (2) WO2006016869A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2008651A1 (en) * 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
EP2100632A1 (en) 2008-03-11 2009-09-16 Pantarhei Devices B.V. Applicator device for body cavity
US8308678B2 (en) 2008-09-23 2012-11-13 Mcneil-Ppc, Inc. Pre-filled applicator device
EP2359750A1 (en) 2010-02-15 2011-08-24 Delphi Bioscience B.V. Screening device with valve
FR2968004B1 (en) 2010-11-29 2013-06-28 Sojasun Technologies BIODEGRADABLE NATURAL FILMS BASED ON CO-PRODUCTS FROM INDUSTRIAL PROCESSES FOR SEED TREATMENT.
RU2538703C2 (en) * 2013-03-12 2015-01-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Pharmaceutical composition for treating vaginal candidiasis and method for preparing it
CN108671366A (en) * 2015-09-18 2018-10-19 赵坚 A kind of device for administration of drugs of external use gynaecological medicine
WO2019241210A1 (en) * 2018-06-11 2019-12-19 The Procter & Gamble Company Methods and applicators for treating vaginal conditions
CN112716796B (en) * 2018-12-11 2022-07-08 管云 Power-assisted medicine dispensing device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636202A (en) * 1984-07-27 1987-01-13 Syntex (U.S.A.) Inc. Medicament applicator with plunger assembly and automatically-openable closure therefor
ES2133090B1 (en) * 1997-02-21 2000-04-01 Uriach & Cia Sa J NEW APPLICATOR FOR THE ADMINISTRATION OF SEMI-SOLID MEDICATIONS.
US6403576B1 (en) * 1998-08-24 2002-06-11 The United States Of America As Represented By The Secretary Of The Navy Antifungal and antiparasitic compounds
US6740333B2 (en) * 2000-07-07 2004-05-25 Anestic Aps Suppository and composition comprising at least one polyethylene glycol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO2006014572A1 *
WEINSTEIN L; HENZEL M R; TSINA I W: "Vaginal retention of 2% butoconazole nitrate cream: comparison of a standard and a sustained-release preparation", CLINICAL THERAPEUTICS, vol. 16, no. 6, 1994, pages 930 - 934, XP008157356 *

Also Published As

Publication number Publication date
AU2005269844A1 (en) 2006-02-09
CN102188375A (en) 2011-09-21
EP1765452A1 (en) 2007-03-28
MX2007000109A (en) 2007-03-26
WO2006016869A1 (en) 2006-02-16
CA2572919A1 (en) 2006-02-09
AU2004100776A4 (en) 2004-11-18
ES1060042Y (en) 2005-11-01
RU2379027C2 (en) 2010-01-20
CN1771023A (en) 2006-05-10
FR2872702B3 (en) 2006-06-02
NZ552406A (en) 2010-07-30
WO2006014572A1 (en) 2006-02-09
BRPI0513066A (en) 2008-04-22
ES1060042U (en) 2005-07-16
CZ15068U1 (en) 2005-01-31
MXPA04007681A (en) 2006-01-12
NL1026978C1 (en) 2006-01-10
FR2872702A3 (en) 2006-01-13
RU2007104782A (en) 2008-08-20

Similar Documents

Publication Publication Date Title
EP1765452A4 (en) Delivery system
HK1250006A1 (en) Combinations and modes of administration of therapeutic agents and combination therapy
PH12018502124A1 (en) Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
MXPA03010402A (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives.
BR0316157A (en) 4-Amino-5-phenyl-7-cyclohexyl-pyrrolo [2,3-d] pyrimidine derivatives
BR112019006228A2 (en) prostate cancer treatment
WO2006029036A3 (en) Combination therapy with glatiramer acetate and n-acetylcysteine for the treatment of multiple sclerosis
MX2021009199A (en) Bi-ligand drug conjugate and use thereof.
BR0306501A (en) Method for use and production of a medicated buffer
RS20070077A (en) Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflamatory diseases
MX2010004373A (en) Non-aqueous water-miscible materials as vehicles for drug delivery.
MY142098A (en) Delivery system
ECSP066836A (en) PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS
MX2021003030A (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain.
JOP20180088B1 (en) Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
TH84091B (en) Delivery system
CO5011086A1 (en) BUDESONIDE ONLY OR IN COMBINATION WITH URSODESOXICOLIC ACID IN THE LIVER DISEASE THERAPY
TH84091A (en) Delivery system
YU17703A (en) New pharmaceutical composition for use on skin
UA36030A (en) Composition for treatment and prophylaxis of respiratory diseases of horses
UA48739U (en) Method for treating acute respiratory diseases of calves

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070108

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1100073

Country of ref document: HK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121030

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/10 20060101ALI20121024BHEP

Ipc: A61K 31/4164 20060101ALI20121024BHEP

Ipc: A61M 31/00 20060101AFI20121024BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130201

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1100073

Country of ref document: HK